Viking Therapeutics Reports Strong Q3 Results with Promising Clinical Progress
Viking Therapeutics Inc (VKTX), a clinical-stage biopharmaceutical company, recently reported its financial results for the third quarter ending September 30, 2024. This…
Browse research
Author: Muzzammil Ahmad
Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product/services forecast as indicated by major brokers covering the stock.
QuantumScape Q3 Earnings: Key Milestone Reached in Solid-State Battery Development
On October 23, 2024, QuantumScape Corp (QS) released its Q3 fiscal 2024 earnings, unveiling significant advancements and a cautious financial outlook. The…
ServiceNow’s Q3 Earnings Beat Forecasts, But Fails to Impress AI-Hungry Investors
ServiceNow Inc (NOW) has reported a strong third quarter for 2024, exceeding its guidance across key financial metrics and raising its subscription…
Newmont Goldcorp’s Q3 Profits Rise on Gold Price Rally and Asset Sales
Newmont Corporation (NEM), a leading gold mining company, recently released its financial results for the third quarter of 2024, highlighting robust operational…
3 Top-Performing Canadian Gold Stocks with Strong Analyst Ratings
The gold sector continues to present valuable opportunities for investors, especially during the current times of economic uncertainty. Canadian gold stocks have…